cas 1207055-69-3|| where to buy N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

Nombre del producto:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

IUPAC Name:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

Unidad de embalaje	Stock disponible	Precio($)	Cantidad

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1207055-69-3 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :1207055-69-3; Fórmula molecular:C22H20N4O2; Punto de fusión:-; Código de sonrisas:O=C(NC1=CC2=C(CCN(C2)C(=O)C2CC2)C=C1)C1=CN=C2C=CC=CC2=N1; Densidad:

: Número de catálogo:CM940087; Peso molecular:372.43; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.